企業プロフィール
Adlai Nortye Ltd. 株価・ニュース・カタリスト
- ティッカー:
- ANL
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
13.34 USD (+0.68%)
終値
最終更新: 2026年8月17日
746M USD
時価総額
株価変動の要因
Following the latest company update, “Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress”, ANL closed up 3.03% at $13.25 on Aug 14, 2026. The move occurred in the trading session associated with this earnings update.
企業概要
事業概要
Annovis Bio is a biotechnology company focused on neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Its story centers on trying to address difficult CNS diseases with a focused molecular approach.
所在地とセクター分類
Annovis is headquartered in the United States and listed on NASDAQ. It sits in neuroscience biotechnology.
ビジネスモデルの特徴
The company depends on clinical proof, translational confidence, and the ability to keep a narrow pipeline funded. Investors usually watch early data and whether the biology can support a meaningful CNS thesis.
バイオ業界での位置付け
Annovis occupies a high-risk neurodegeneration niche within biotech. The stock is highly dependent on whether the company can show a real disease-modifying effect.
今後のカタリスト
- Adlai Nortye’s catalysts are its oncology pipeline and any clinical update that clarifies whether the company can still build a meaningful development story. The stock remains early and data-dependent.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。